Medical device licence · 1092 · Class 3
ANTI-HUMAN GLOBULIN
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed February 5, 1999; ended October 23, 2006. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 1092
- Licence holder
- Immucor Inc.Norcross, GA, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- Device Group
- First licensed
- February 5, 1999
- Ended
- October 23, 2006
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- ANTI-C3B, -C3D ANTI-HUMAN GLOBULIN (RABBIT)
- ANTI-IGG ANTI-HUMAN GLOBULIN (RABBIT) (CLEAR OR GREEN)
- ANTI-IGG, -C3B POLYSPECIFIC ANTI-HUMAN GLOBULIN
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.